| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2207141
Max Phase: Preclinical
Molecular Formula: C12H20N2O6
Molecular Weight: 288.30
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)OCC(=O)O
Standard InChI: InChI=1S/C12H20N2O6/c1-7(2)4-9(14-8(3)15)12(19)13-5-11(18)20-6-10(16)17/h7,9H,4-6H2,1-3H3,(H,13,19)(H,14,15)(H,16,17)/t9-/m0/s1
Standard InChI Key: OSYOVGIYSURCJJ-VIFPVBQESA-N
Associated Targets(Human)
Peptidyl-glycine alpha-amidating monooxygenase 90 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 288.30 | Molecular Weight (Monoisotopic): 288.1321 | AlogP: -0.72 | #Rotatable Bonds: 8 |
| Polar Surface Area: 121.80 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.46 | CX Basic pKa: | CX LogP: -0.99 | CX LogD: -4.37 |
| Aromatic Rings: 0 | Heavy Atoms: 20 | QED Weighted: 0.51 | Np Likeness Score: -0.29 |
References
| 1. Morris KM, Cao F, Onagi H, Altamore TM, Gamble AB, Easton CJ.. (2012) Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency., 22 (23): [PMID:23084901] [10.1016/j.bmcl.2012.10.004] |
Source
Source(1):